Predictors of exacerbation in Japanese patients with severe asthma: Analysis of the severe asthma research program (Okayama-SARP) cohort
- 29 May 2024
- journal article
- research article
- Published by Elsevier in Respiratory Investigation
- Vol. 62 (4) , 695-701
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)Allergology International, 2022
- Eosinophilic and Noneosinophilic AsthmaChest, 2021
- Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in JapanAllergology International, 2020
- Predicting future risk of exacerbations in Japanese patients with adult asthma: A prospective 1-year follow up studyAllergology International, 2017
- Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator–inducible T-cell costimulator ligand interactionJournal of Allergy and Clinical Immunology, 2017
- Japanese guidelines for adult asthma 2017Allergology International, 2017
- Pharmacokinetics and pharmacodynamics of mepolizumab, an anti–interleukin 5 monoclonal antibody, in healthy Japanese male subjectsClinical Pharmacology in Drug Development, 2015
- An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell NumbersImmunity, 2015
- The prevalence of severe refractory asthmaJournal of Allergy and Clinical Immunology, 2015
- Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroidsJournal of Allergy and Clinical Immunology, 2011